Search filters

List of works by Hugo Horlings

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

scientific article published on 12 May 2020

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival

scientific article published on 11 September 2018

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

scientific article

Characteristics and Outcome of AKT1 E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry

scientific article published on 10 January 2020

Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters

scientific article

Functional characterization of the 19q12 amplicon in grade III breast cancers

scientific article

Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes

scientific article published on 24 April 2017

Genomic profiling of histological special types of breast cancer

scientific article published on 27 October 2013

IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women

scientific article published on 20 October 2021

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

scientific article published on 13 May 2019

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

scientific article published on 12 May 2020

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

scientific article published on 01 July 2019

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

scientific article published on 07 August 2020

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

scientific article published on 27 September 2021

The NFκB pathway promotes tamoxifen tolerance and disease recurrence in estrogen receptor positive breast cancers

scientific article published on 03 April 2020